ARMP
Armata Pharmaceuticals, Inc. · AMEX
- Sector Health Technology
- Industry Biotechnology
- Website armatapharma.com
- Employees(FY) 72
- ISIN US04216R1023
Performance
-20.55%
1W
-19.06%
1M
-11.9%
3M
+28.86%
6M
-20.06%
YTD
+107.2%
1Y
Profile
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Technical Analysis of ARMP 2024-05-10
Overview:
In the last 5 trading days, ARMP stock has shown mixed price movements with fluctuating volume levels. The trend indicators suggest a slightly bearish sentiment, while momentum indicators show a potential for a bullish reversal. Volatility indicators indicate increasing price fluctuations, and volume indicators reflect a slightly negat...
Recent News & Updates
- 2024-05-07 04:01
- 2024-03-21 04:05
- 2024-03-04 03:01
- 2024-02-20 18:00
- 2023-11-14 03:00
- 2023-10-29 20:00
- 2023-10-18 20:00
- 2023-09-25 20:00
- 2023-09-20 19:00
- 2023-08-16 21:55
- 2023-08-13 19:00
- 2023-07-10 20:00
- 2023-05-30 20:00
- 2023-05-11 04:05
- 2023-03-16 04:10
- 2023-03-05 17:00
- 2023-01-10 03:05
- 2022-12-21 19:00
- 2022-12-07 20:55
- 2022-11-27 20:35
- 2022-11-27 19:00
- 2022-11-14 20:55
- 2022-11-09 03:15
- 2022-08-11 04:05
- 2022-07-31 20:00
- 2022-05-22 20:00
- 2022-05-12 04:17
- 2022-03-31 04:05
- 2022-03-21 22:00
- 2022-03-17 04:05
Page 1 of 3
previousnext